Nascent Biotech, Inc.
NBIO · OTC
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,088 | -$2,801 | -$470 | -$959 |
| Dep. & Amort. | $0 | $1,343 | $0 | $0 |
| Deferred Tax | $0 | $246 | $0 | $0 |
| Stock-Based Comp. | $882 | $756 | $116 | $786 |
| Change in WC | $164 | -$317 | $911 | -$103 |
| Other Non-Cash | -$144 | -$1,014 | -$143 | -$711 |
| Operating Cash Flow | -$1,186 | -$1,787 | $413 | -$987 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$175 | $1,657 | -$321 | $345 |
| Stock Issued | $1,561 | $208 | $0 | $640 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $1,386 | $1,865 | -$321 | $985 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $200 | $78 | $93 | -$2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $172 | $94 | $1 | $3 |
| End Cash | $372 | $172 | $94 | $1 |
| Free Cash Flow | -$1,186 | -$1,787 | $413 | -$987 |